Lotrafilcon A contact lenses

DEVICE6 trials

Sponsors

University Hospitals Cleveland Medical Center, CIBA VISION, Alcon Research

Conditions

Bell PalsyBullous KeratopathyCorneal DystrophyCorneal EdemaCorneal ErosionCorneal Infiltrative EventsCorneal UlcerDry Eye

Phase 4

Daily Wear Corneal Infiltrative Event Study

CompletedNCT00937105

University Hospitals Cleveland Medical CenterCorneal Infiltrative Events, Hyperopia, Myopia

Start: 2009-11-30End: 2012-02-29Updated: 2014-03-10

Unknown Phase

Effect of Contact Lenses on Tear Osmolarity in a Controlled Low Humidity Chamber

CompletedNCT01482312

CIBA VISIONDry Eye, Myopia

Start: 2010-12-31End: 2011-02-28Updated: 2012-07-27

AONDA Therapeutic Indication Study I

CompletedNCT05891106

Alcon ResearchBell Palsy, Bullous Keratopathy, Corneal Dystrophy +8

Start: 2023-06-28End: 2023-07-10Updated: 2023-07-20

Air Optix® Night and Day® Aqua Therapeutic Wear

CompletedNCT05956535

Alcon ResearchBullous Keratopathy, Corneal Dystrophy, Corneal Edema +2

Start: 2023-09-26End: 2024-10-25Updated: 2024-11-13

Air Optix® Night and Day® Aqua Daily Wear

CompletedNCT05976750

Alcon ResearchHyperopia, Myopia, Refractive Errors

Start: 2023-10-03End: 2024-07-30Updated: 2024-08-09

Air Optix® Night and Day® Aqua Continuous Wear

CompletedNCT05992675

Alcon ResearchRefractive Errors

Start: 2023-10-05End: 2024-08-22Updated: 2024-09-19